Sglt2 Inhibitors Market Growth, Trends, and Global Forecast (2024–2032)
Sglt2 (Sodium-Glucose Cotransporter 2) inhibitors represent a specialized class of oral medications primarily used to lower blood sugar in adults with type 2 diabetes. Often referred to as “gliflozins,” these therapeutic agents function by preventing the kidneys from reabsorbing glucose … Read more